Histone Deacetylase Inhibition Alters Stem Cell Phenotype in Gefitinib-Resistant Lung Cancer Cells with EGFR Mutation

被引：0
|
作者：
Nurwidya, F. [1 ]
Takahashi, F. [2 ]
Hidayat, M. [2 ]
Kobayashi, I. [2 ]
Wirawan, A. [2 ]
Kato, M. [2 ]
Tajima, K. [2 ]
Shimada, N. [2 ]
Takeda, I. [2 ]
Tajima, M. [2 ]
Matsumoto, N. [2 ]
Kanemori, K. [2 ]
Koinuma, Y. [2 ]
Yunus, F. [1 ]
Andarini, S. [1 ]
Takahashi, K. [2 ]
机构：
[1] Univ Indonesia, Dept Pulmonol & Resp Med, Jakarta, Indonesia
[2] Juntendo Univ, Dept Resp Med, Bunkyo Ku, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Cancer Stem Cells; acquired resistance to EGFR-TKI; HDACs;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.02-065
引用
收藏
页码：S1947 / S1947
页数：1
相关论文
共 50 条
  • [1] The Role of Histone Deacetylase in the Maintenance of Gefitinib-Resistant Lung Cancer Stem Cells with Epidermal Growth Factor Receptor Mutation
    Nurwidya, F.
    Takahashi, F.
    Hidayat, M.
    Wirawan, A.
    Baskoro, H.
    Kato, M.
    Tajima, K.
    Shimada, N.
    Andarini, S. L.
    Yunus, F.
    Takahashi, K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [2] Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
    Tang, Mei-Chuan
    Wu, Mei-Yi
    Hwang, Ming-Hung
    Chang, Ya-Ting
    Huang, Hui-Ju
    Lin, Anya Maan-Yuh
    Yang, James Chih-Hsin
    [J]. PLOS ONE, 2015, 10 (03):
  • [3] Role of FBXW7 in the quiescence of gefitinib-resistant lung cancer stem cells in EGFR-mutant non-small cell lung cancer
    Hidayat, Moulid
    Mitsuishi, Yoichiro
    Takahashi, Fumiyuki
    Tajima, Ken
    Yae, Toshifumi
    Miyahara, Katsumi
    Hayakawa, Daisuke
    Winardi, Wira
    Ihara, Hiroaki
    Koinuma, Yoshika
    Wirawan, Aditya
    Nurwidya, Fariz
    Kato, Motoyasu
    Kobayashi, Isao
    Sasaki, Shinichi
    Takamochi, Kazuya
    Hayashi, Takuo
    Suehara, Yoshiyuki
    Moriyama, Mariko
    Moriyama, Hiroyuki
    Habu, Sonoko
    Takahashi, Kazuhisa
    [J]. BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2019, 19 (04) : 355 - 367
  • [4] Anti-Proliferative Effect of Cytohesin Inhibition in Gefitinib-Resistant Lung Cancer Cells
    Bill, Anke
    Schmitz, Anton
    Koenig, Katharina
    Heukamp, Lukas C.
    Hannam, Jeffrey S.
    Famulok, Michael
    [J]. PLOS ONE, 2012, 7 (07):
  • [5] Erlotinib response EGFR-mutant gefitinib-resistant non-small-cell lung cancer
    Chang, John Wen-Cheng
    Chou, Chun-Liang
    Huang, Shiu-Feng
    Wang, Hung-Ming
    Hsieh, Jia-Juan
    Hsu, Todd
    Cheung, Yun-Chung
    [J]. LUNG CANCER, 2007, 58 (03) : 414 - 417
  • [6] Cancer Stem-like traits are up-regulated in gefitinib-resistant lung cancer cells
    Reheman, Yiming
    Takeuchi, Yasuto
    Nishimura, Tatsunori
    Nakata, Asuka
    Gotoh, Noriko
    [J]. CANCER SCIENCE, 2021, 112 : 697 - 697
  • [7] Small cell lung cancer with an epidermal growth factor receptor mutation in primary gefitinib-resistant adenocarcinoma of the lung
    Ma, Ada T. W.
    Chan, Wai Kong
    Ma, Edmond S. K.
    Cheng, Thomas
    Cheng, Paul N. M.
    [J]. ACTA ONCOLOGICA, 2012, 51 (04) : 557 - U169
  • [8] 3-Deoxysappanchalcone Inhibits Cell Growth of Gefitinib-Resistant Lung Cancer Cells by Simultaneous Targeting of EGFR and MET Kinases
    Lee, Jin-Young
    Lee, Seung-On
    Kwak, Ah-Won
    Chae, Seon-Bin
    Cho, Seung-Sik
    Yoon, Goo
    Kim, Ki-Taek
    Choi, Yung Hyun
    Lee, Mee-Hyun
    Joo, Sang Hoon
    Park, Jin Woo
    Shim, Jung-Hyun
    [J]. BIOMOLECULES & THERAPEUTICS, 2023, 31 (04) : 446 - 455
  • [9] Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R
    Gow, CH
    Shih, JY
    Chang, YL
    Yu, CJ
    [J]. PLOS MEDICINE, 2005, 2 (09): : 924 - 925
  • [10] Clinical Significance of Erlotinib Monotherapy for Gefitinib-resistant Non-small Cell Lung Cancer with EGFR Mutations
    Koyama, Nobuyuki
    Uchida, Yoshitaka
    [J]. ANTICANCER RESEARCH, 2013, 33 (11) : 5083 - 5089
12345